SLC6A3 and Tics: This notion is supported by clinical findings as DA antagonists ameliorate and DA stimulants exacerbate tics, respectively.75, 76 In line, DAT-tg rats display a general decrease in DA levels and increase in DA turnover due to DAT overexpression.